Home
>
US Stocks
>
Repligen Corp.
Repligen Corp.
RGEN

Repligen Corp. (RGEN)

$275.250.94%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
270.81
Today Low/High
267.99 / 275.36
52 Week Low/High
$138 / $258.24
P/E ratio
141.19
Market Cap
$14.11B

Company Details

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. Its primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Its corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of its manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. it has sites in Estonia, Germany, Ireland, the Netherlands and Sweden.
Organisation
Repligen Corp.
Headquaters
Waltham, Massachusetts, US
Employees
1.13K
Industry
Health Technology
CEO
Anthony Hunt
Company Financials
  • Annual P&L
  • Quarterly P&L

Discover more

Frequently Asked Questions

What is Repligen Corp. (RGEN) share price today?

Can Indians buy Repligen Corp. (RGEN) shares?

How can I buy Repligen Corp. (RGEN) shares from India?

Can Fractional shares of Repligen Corp. (RGEN) be purchased?

What are the documents required to start investing in Repligen Corp. (RGEN) stocks?

We are a SEBI registered investement advisor